A Randomized Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 3200 participants.
Also called NCT03947229
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 3,200 participants
- Sponsor
- Registry
-
NCT03947229
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT03947229. Randomized; no masking; primary purpose treatment. Start 2019-08-14 (actual); primary completion 2025-08-16 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Randomized Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial
- Condition
- Coronary Artery Disease
- Condition
- DES
- Intervention (Drug)
- Clopidogrel mono-therapy
- Intervention (Drug)
- Dual-antiplatelet therapy
- Lead sponsor
- Yonsei University
Record details
- Record id
cardio:ct-nct03947229- Content hash
2dffe3df55e9dfd7d5f3831b134360d05a56afb1893f3296ec206574cc56f13b